Summer 2023

Practical Pearls: Impact and Inclusivity - How the NLA Does It

History We recently celebrated the twentieth anniversary of the NLA in 2022. It seems appropriate, when considering the impact of the NLA on the healthcare community, to reflect upon the environment in which the NLA was conceived, fostered, and evolved.    In 1987 we started a lipid... more

Case Study: A Patient with Familial Hypercholesterolemia and Statin-Associated Muscle Effects: Pharmacotherapy and Lifestyle

Introduction Atherosclerotic cardiovascular disease (ASCVD) is an umbrella term for atherosclerotic conditions that affect the cardiovascular system, including ischemic heart disease, peripheral artery disease, and ischemic stroke. The public health impact of ASCVD is hard to overstate, it is... more

MWLA Chapter Update: Our Small Steps towards Big Goals

The Midwest Lipid Association (MWLA) would like to congratulate and express deep appreciation to all authors and co-editors, Drs. Willard and Braun, who are MWLA Board members, for the enlightening Summer Edition of LipidSpin with emphasis on “NLA impact on the Health Community”.... more

Member Spotlight: LSP Recipient

Chad Morreale, DO Cardiovascular Disease Fellow Division of Cardiology Advocate Lutheran General Hospital Chicago, IL  Dr. Chad Morreale is currently at General Cardiology Fellow at Advocate Lutheran General Hospital. As a Chicagoland native, Dr Morreale attended Purdue... more